drugset / Trial / NCT00601965

Antidepressant Treatment Plus Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older Adults

NCT00601965 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will assess whether adding cognitive behavioral therapy to the antidepressant escitalopram is effective in reducing anxiety in older adults with generalized anxiety disorder.

Timeline

Start
2007-10
Primary completion
2011-09
Completion
2011-09

Outcome

Met primary endpoint

paper Both escitalopram and CBT prevented relapse compared with placebo. PMID 23680817 ↗

registry MEAN Escitalopram + CBT: 52.8 (Standard Deviation 2.6) units on a scale NCT00601965 ↗

registry Escitalopram + CBT vs Escitalopram + no CBT vs Placebo + CBT vs Placebo + no CBT; p = 0.01; Mixed Models Analysis NCT00601965 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 20 mg Oral